GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,451,000 | -82.5% | 30,000 | -82.9% | 0.64% | -79.2% |
Q1 2018 | $19,721,000 | +21.5% | 175,030 | +42.4% | 3.07% | +15.8% |
Q4 2017 | $16,228,000 | +184.7% | 122,930 | -63.1% | 2.65% | +162.2% |
Q3 2013 | $5,700,000 | +131.0% | 332,936 | +18.9% | 1.01% | +109.5% |
Q2 2013 | $2,467,000 | – | 280,000 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |